Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067080
Status:
COMPLETED
Last Update Posted:
2017-08-22
First Post:
2003-08-11
Brief Title:
Safety of ICL670 vs Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-05
Start Date Type:
None
Primary Completion Date:
2007-07
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2003-08-11
First Submit QC Date:
August 12 2003
Study First Post Date:
2003-08-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-18
Last Update Post Date:
2017-08-22
Last Update Post Date Type:
ACTUAL